Cho-A Pharmaceutical. Co

Company snapshot

Since our inaugural export to Vietnam in 1995, Cho A Pharm has consistently grown its global presence by distributing our products across various regions, including the Middle East, Asia, America, and South Africa. We have forged partnerships with over 40 overseas collaborators, including those in the USA, Guatemala, Iran, Vietnam, China, Georgia, and more. With our dedicated manufacturing facilit

• 1 active pipeline program(s) linked via ClinicalTrials.gov.
• 1 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Cho-A Pharmaceutical. Co. Not investment advice.

• What is Cho-A Pharmaceutical. Co?

  Cho Pharma is a pharma organization headquartered in CN. Primary therapeutic focus areas include Non-Hodgkin Lymphoma. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources.

• Is Cho-A Pharmaceutical. Co publicly traded?

  Cho-A Pharmaceutical. Co appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Cho-A Pharmaceutical. Co develop or market?

  No drug profiles are currently linked to Cho-A Pharmaceutical. Co. Pipeline programs may still list investigational assets.

• What are the latest developments for Cho-A Pharmaceutical. Co?

  In the last 12 months our linked public records show 1 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Cho-A Pharmaceutical. Co focus on?

  Cho-A Pharmaceutical. Co focuses on Non-Hodgkin Lymphoma based on our analysis of their pipeline programs and drug development activities.